These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 3940937

  • 1. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease.
    Schlechte JA, Sherman B, Pfohl B.
    Horm Res; 1986; 23(1):1-8. PubMed ID: 3940937
    [Abstract] [Full Text] [Related]

  • 2. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
    Görges R, Knappe G, Gerl H, Ventz M, Stahl F.
    J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
    [Abstract] [Full Text] [Related]

  • 4. Circadian rhythm of serum cortisol in Cushing's disease.
    Glass AR, Zavadil AP, Halberg F, Cornelissen G, Schaaf M.
    J Clin Endocrinol Metab; 1984 Jul; 59(1):161-5. PubMed ID: 6725521
    [Abstract] [Full Text] [Related]

  • 5. Spot determinations of urinary cortisol for the screening of Cushing's syndrome.
    Fujita H, Hata K, Ogata E, Kojima I.
    Endocrinol Jpn; 1991 Aug; 38(4):441-4. PubMed ID: 1802685
    [Abstract] [Full Text] [Related]

  • 6. The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing's disease.
    Odagiri E, Demura R, Demura H, Suda T, Ishiwatari N, Abe Y, Jibiki K, Shizume K.
    Endocrinol Jpn; 1988 Dec; 35(6):795-802. PubMed ID: 3250858
    [Abstract] [Full Text] [Related]

  • 7. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
    Montwill J, Igoe D, McKenna TJ.
    Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
    [Abstract] [Full Text] [Related]

  • 8. 24-hour serum concentration profile of cortisol in patients with Cushing's disease.
    Pirich K, Vierhapper H.
    Exp Clin Endocrinol; 1988 Mar; 92(3):275-9. PubMed ID: 2855318
    [Abstract] [Full Text] [Related]

  • 9. Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome.
    Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR.
    Br Med J (Clin Res Ed); 1984 Nov 03; 289(6453):1188-91. PubMed ID: 6437479
    [Abstract] [Full Text] [Related]

  • 10. Salivary cortisol levels in true and apparent hypercortisolism.
    Evans PJ, Peters JR, Dyas J, Walker RF, Riad-Fahmy D, Hall R.
    Clin Endocrinol (Oxf); 1984 Jun 03; 20(6):709-15. PubMed ID: 6467636
    [Abstract] [Full Text] [Related]

  • 11. [Comparison between the value of urinary free cortisol and 17-hydroxycorticosteroids for the diagnosis of Cushing's syndrome].
    Billon-Rey S, Beylot M, Mathian B, Patricot MC, Berthezene F, Mornex R, Revol A.
    Presse Med; 1986 May 24; 15(21):965-8. PubMed ID: 2942852
    [Abstract] [Full Text] [Related]

  • 12. Urinary cortisol in the assessment of pituitary-adrenal function: utility of 24-hour and spot determinations.
    Contreras LN, Hane S, Tyrrell JB.
    J Clin Endocrinol Metab; 1986 May 24; 62(5):965-9. PubMed ID: 3958132
    [Abstract] [Full Text] [Related]

  • 13. Serum cortisol levels in Cushing's syndrome after low- and high-dose dexamethasone suppression.
    Ashcraft MW, Van Herle AJ, Vener SL, Geffner DL.
    Ann Intern Med; 1982 Jul 24; 97(1):21-6. PubMed ID: 6212010
    [Abstract] [Full Text] [Related]

  • 14. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA, Cutler GB, Chrousos GP, Nieman LK.
    JAMA; 1993 May 05; 269(17):2232-8. PubMed ID: 8386285
    [Abstract] [Full Text] [Related]

  • 15. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE, McKenzie AK.
    J Clin Endocrinol Metab; 1980 Nov 05; 51(5):1195-8. PubMed ID: 6252234
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB.
    J Clin Endocrinol Metab; 1994 Feb 05; 78(2):418-22. PubMed ID: 8106630
    [Abstract] [Full Text] [Related]

  • 17. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct 05; 65(10):474-82. PubMed ID: 12523812
    [Abstract] [Full Text] [Related]

  • 18. Cushing's syndrome. Screening methods in hospitalized patients.
    Dunlap NE, Grizzle WE, Siegel AL.
    Arch Pathol Lab Med; 1985 Mar 05; 109(3):222-9. PubMed ID: 3838451
    [Abstract] [Full Text] [Related]

  • 19. Cushing's disease with intermittent hypercortisolism.
    Vagnucci AH, Evans E.
    Am J Med; 1986 Jan 05; 80(1):83-8. PubMed ID: 3942155
    [Abstract] [Full Text] [Related]

  • 20. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug 05; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.